Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android


Cerebrospinal fluid (CSF) is produced by the choroid plexus that lines the cerebral ventricles at a rate of 15 to 30 mL/h, or approximately 500 mL/d in adults.50 CsF flows in a rostral to caudal direction and is resorbed through the arachnoid villi directly into the venous circulation. The estimated total volume of CSF is 130 to 150 mL in healthy adults and 35 mL in infants.50,66,89

For more than 100 years, a variety of experimental and therapeutic xenobiotics have been delivered directly into the CSF57,116 (Table SC3–1). The most common current indications for intrathecal administration include analgesia, anesthesia, and treatment of spasticity or central nervous system (CNS) neoplasms. The clinical advantages of this route of administration include targeted delivery and lower medication dosages with fewer systemic effects. Medications are usually administered via a spinal needle or an indwelling intrathecal catheter. Catheters may be attached to either an external or subcutaneous pump. Less commonly, medications are administered into a reservoir of an intraventricular shunt. The distribution of intrathecal xenobiotics is determined by a variety of factors. Some authors speculate that the xenobiotic movement is often attributed to both diffusion and convection, and they suggest that the dilution of xenobiotics administered via a lumbar catheter is attributed to the outflow of CSF from the fourth ventricle.82 In a radiolabeled tracer study of five patients with lumbar catheters, individuals received the hydrophilic radiolabeled diethylene triamine pentaacetic acid (111 In-DTPA) intrathecally. Neuroimaging revealed a drop in concentration of the tracer as the fluid moved rostrally.59 The steady-state lumbar to cervical concentration for hydrophilic xenobiotics is 4:1 with marked interindividual variability.86 Depending on the lipophilicity, the xenobiotic reaches the brain within a few minutes to 1 hour. Patient position and interindividual variations in lumbosacral CSF volume may affect xenobiotic distribution and may account for the differences in the level of spinal anesthesia among patients administered the same local anesthetic dosages.48 Baricity, which is the ratio of the specific gravity of the xenobiotic to the specific gravity of CSF at 98.6°F (37°C), is also a consequential variable. Hyperbaric xenobiotics typically distribute in accordance with gravitational forces.48 However, in overdose or administration of xenobiotics unintended for intrathecal administration, distribution, resorption, and clinical effects may not follow predictable models.

TABLE SC3–1.Xenobiotics Administered Intrathecallya

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.